about
Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK.Differential protein profiling as a potential multi-marker approach for TSE diagnosisNeuropathology and molecular biology of variant Creutzfeldt-Jakob disease.Application of an immunocapillary electrophoresis assay to the detection of abnormal prion protein in brain, spleen and blood specimens from patients with variant Creutzfeldt-Jakob disease.No major change in vCJD agent strain after secondary transmission via blood transfusionGerstmann-Straüssler-Scheinker disease: novel PRNP mutation and VGKC-complex antibodies.Laboratory diagnosis of variant Creutzfeldt-Jakob disease.A prion protein epitope selective for the pathologically misfolded conformation.Genotype-dependent molecular evolution of sheep bovine spongiform encephalopathy (BSE) prions in vitro affects their zoonotic potentialDistinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassayPreclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.Investigation of prion diseases.The prion protein protease sensitivity, stability and seeding activity in variably protease sensitive prionopathy brain tissue suggests molecular overlaps with sporadic Creutzfeldt-Jakob disease.Variant CJD. 18 years of research and surveillance.A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann-Sträussler-Scheinker disease phenotype: comparison with similar cases from the literature.In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc.Molecular model of prion transmission to humans.Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.The transmissible spongiform encephalopathies: pathogenic mechanisms and strategies for therapeutic intervention.Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease.Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study.Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob diseasePrion protein accumulation and neuroprotection in hypoxic brain damage.Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease.Abnormal prion protein in the retina of the most commonly occurring subtype of sporadic Creutzfeldt-Jakob disease.vCJD and the gut: implications for endoscopyFatal encephalopathy with astrocyte inclusions in GFAP transgenic miceThe Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease PatientsSensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion.Application of Atomic Dielectric Resonance Spectroscopy for the screening of blood samples from patients with clinical variant and sporadic CJD.Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob diseasePhenotypic variability in human prion diseases.Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPScAgeing in the chick lens: in vitro studies.Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes.Molecular barriers to zoonotic transmission of prions.UK Iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approachesThe application of in vitro cell-free conversion systems to human prion diseases.The contribution of different prion protein types and host polymorphisms to clinicopathological variations in Creutzfeldt-Jakob disease.Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain.
P50
Q30488585-3B06B422-66D0-4FAE-A48E-D7EE5FF7A593Q30923316-80B50155-77CA-4A1B-B9A1-8F89D7E9D2F3Q30932140-3DED9E48-4D84-4481-A17C-ED36781F7FD6Q33256978-DA3374F3-F47D-48FA-90F6-C06C4322E8DBQ33358045-80E04F5A-BC80-4FBB-A576-9CD9B016FAE0Q33987193-64A514E6-DBA1-4C07-83FB-A12CAFA61EEAQ33994500-B951A42C-2DDD-451B-9771-80561D6F0414Q34201802-710AE5E4-8CFE-4C1C-9299-3F79CC5D5760Q34249065-744EC42D-B5ED-4D15-8701-35C3676A12C4Q34296117-9AFB1F7F-6970-44A5-922D-50DE9F784154Q34339769-83C494F0-ACA5-4B08-8FD7-3A20EF52A4D3Q34361632-F01ECD8A-0875-41FE-8B71-A6F5D8C2E9FEQ34410655-0435830A-9B38-477B-9A6C-EAB4375CE0CDQ34453109-66C855BE-8CFC-463E-BD89-710063B8FCCAQ34463067-790A7766-D705-4278-9CDA-801AA5ADA896Q34580924-E7E33488-B6EC-49ED-BCB9-89D8E5200ED5Q34603607-AD3AC523-963F-4D8A-94B3-383A6D5101C0Q34646980-89F43126-7D73-4A35-AE5A-8C3D8380DA7CQ35050425-9C252271-BD14-490C-9C20-818AC534AA56Q35070708-0FFDC3A4-EBDA-41B2-B315-26C382B027F3Q35083260-CBCE94F6-31BC-4FD3-92BF-085C98DDDEB2Q35088040-A65196DD-1831-42C9-B37C-5890CD38E620Q35102832-57325A87-9E6C-4E71-BAA2-7DCB4374C728Q35587468-03882654-0479-4E79-9893-965EEC5E9DD4Q35593696-2982753A-BCAB-4D7B-9C2C-8071072DB946Q35761229-BCD8A6B8-5EE0-413B-9B4D-354822C196E3Q35763724-F3642B00-D0B3-4953-9DBF-3646673134FCQ35913122-743BE07B-59FE-4426-A813-429A0F2C87FCQ35960528-637C4EEB-230E-4ABA-81F0-58D64AE533A7Q36037527-2D413051-C55E-4021-A4CB-D3F75A9D2529Q36281277-4AFBAD46-7226-42B3-ADE5-20F34F05E455Q36310865-016429B6-A7E6-4644-B1A3-4BBB46A52F7CQ36672125-699D05CD-661F-4FB7-8EA7-9337E1C27309Q36706715-57662BEF-0427-4EAB-9CC3-4DC52B326903Q37415409-AD599A7D-153A-479F-9643-F7EB14DBFC8FQ37449082-41AB2DA3-0C77-4F46-8100-D8DD0D3C176CQ37697473-E475FC4F-8110-4857-99F4-D42B3BAFC3ECQ37763862-871724F9-AF8E-48DF-A033-E09FA951CA80Q37989099-40FC209C-FADB-493E-9D5A-C3A373724F08Q37990996-BCAA0AA1-9A84-4700-BAA3-BFE403EB254A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mark W Head
@ast
Mark W Head
@en
Mark W Head
@es
Mark W Head
@nl
Mark W Head
@sl
type
label
Mark W Head
@ast
Mark W Head
@en
Mark W Head
@es
Mark W Head
@nl
Mark W Head
@sl
prefLabel
Mark W Head
@ast
Mark W Head
@en
Mark W Head
@es
Mark W Head
@nl
Mark W Head
@sl
P106
P31
P496
0000-0003-2034-8613